These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12603221)

  • 21. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
    Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment with telaprevir of post-transplant fibrosing cholestatic hepatitis C in an HIV co-infected patient.
    Marciano S; Galdame OA; Barcan LA; Gadano AC
    Acta Gastroenterol Latinoam; 2015 Mar; 45(1):76-9. PubMed ID: 26076519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C.
    Ciccorossi P; Maina AM; Oliveri F; Petruccelli S; Leandro G; Colombatto P; Moriconi F; Mosca F; Filipponi F; Bonino F; Brunetto MR
    Liver Int; 2007 Jun; 27(5):612-9. PubMed ID: 17498245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation.
    Kaneko J; Sugawara Y; Akamatsu N; Kokudo N; Makuuchi M
    Hepatogastroenterology; 2004; 51(55):243-4. PubMed ID: 15011874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.
    Grassi A; Ballardini G
    World J Gastroenterol; 2014 Aug; 20(32):11095-115. PubMed ID: 25170198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
    Jung BH; Park JI; Lee SG
    Transplant Proc; 2018 Nov; 50(9):2877-2881. PubMed ID: 30401415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.
    Gaglio PJ; Malireddy S; Levitt BS; Lapointe-Rudow D; Lefkowitch J; Kinkhabwala M; Russo MW; Emond JC; Brown RS
    Liver Transpl; 2003 Oct; 9(10):1028-35. PubMed ID: 14526396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
    Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
    Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
    Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation.
    Hori T; Egawa H; Takada Y; Oike F; Ogura Y; Ogawa K; Kaido T; Toshimitsu Y; Yagi S; Iida T; Nguyen JH; Uemoto S
    Transpl Int; 2010 Mar; 23(3):338-40. PubMed ID: 19725911
    [No Abstract]   [Full Text] [Related]  

  • 33. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors.
    Schiano TD; Gutierrez JA; Walewski JL; Fiel MI; Cheng B; Bodenheimer H; Thung SN; Chung RT; Schwartz ME; Bodian C; Branch AD
    Hepatology; 2005 Dec; 42(6):1420-8. PubMed ID: 16317672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus recurrence in living donor liver transplant recipients.
    Rodriguez-Luna H; Vargas HE; Sharma P; Ortiz J; De Petris G; Balan V; Byrne T; Moss A; Mulligan D; Rakela J; Douglas DD
    Dig Dis Sci; 2004 Jan; 49(1):38-41. PubMed ID: 14992432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus-related fibrosing cholestatic hepatitis in a renal transplant recipient.
    Hooda AK; Puri P; Narula AS; Raychaudhury N; Varghese SJ; Basu A
    Indian J Gastroenterol; 2006; 25(6):308-9. PubMed ID: 17264433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
    Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
    Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs.
    Adekunle R; Jonchhe S; Ravichandran B; Wilson E; Husson J
    Transpl Infect Dis; 2018 Aug; 20(4):e12925. PubMed ID: 29797655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review.
    Tronina O; Ślubowska K; Mikołajczyk-Korniak N; Komuda-Leszek E; Wieczorek-Godlewska R; Łągiewska B; Pacholczyk M; Lisik W; Kosieradzki M; Durlik M
    Transplant Proc; 2017; 49(6):1409-1418. PubMed ID: 28736015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus infection in a living-related liver donor.
    Gruttadauria S; Pagano D; Petridis I; Vizzini G; Volpes R; Grossi PA; Gridelli B
    Am J Transplant; 2010 Jan; 10(1):191. PubMed ID: 19951282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.